Grants for Public Housing Authorities

This funding opportunity provides additional financial support for early-stage cancer researchers with active NCI R37 grants, allowing them to continue their innovative work in cancer prevention, detection, and treatment for an extra two years.

This funding opportunity supports research and evaluation projects that address the needs of special populations in corrections, improve workforce management, and enhance correctional culture and safety, inviting a wide range of organizations to collaborate on innovative solutions.

This funding opportunity supports clinical trials that develop and test new treatments for communication disorders, such as those affecting hearing, speech, and language, and is open to a wide range of eligible organizations, including universities and nonprofits.

This funding opportunity supports multi-site clinical trials aimed at testing high-risk medical interventions for diseases related to diabetes, digestive disorders, and kidney health, targeting a wide range of eligible organizations including universities, nonprofits, and businesses.

This funding opportunity provides financial support for short-term research training experiences for health professional and graduate students in biomedical, behavioral, or clinical research, helping them prepare for careers in scientific research.

This funding opportunity supports high-risk, multi-center observational studies aimed at improving understanding and treatment of diabetes, digestive diseases, and kidney-related conditions, targeting a wide range of eligible public and private institutions.

This funding opportunity provides financial support for research and evaluation projects aimed at improving youth justice systems, focusing on prosecution, defense delivery, reentry practices, and system reforms to better serve justice-involved youth.

This funding opportunity supports research projects aimed at developing safe and effective medications for treating substance use disorders, particularly for substances like cocaine, methamphetamine, and cannabis, and is open to a wide range of eligible institutions and organizations.

This funding opportunity provides financial support for research and evaluation projects aimed at improving policing practices, enhancing community relations, and ensuring evidence-based policymaking, targeting a wide range of eligible applicants including government entities, educational institutions, and nonprofit organizations.

This funding opportunity supports researchers in analyzing existing vision-related health data to develop innovative solutions for preventing and treating blindness and impaired vision in the U.S.

This funding opportunity supports doctoral candidates conducting research on substance use and addiction, focusing on innovative approaches to prevention, treatment, and health disparities among underserved populations.

This grant provides funding for collaborative projects between academic institutions and industry partners to develop and validate innovative technologies for disease diagnosis and treatment.

This funding opportunity supports researchers with active NCI U01 awards who want to integrate innovative cancer research technologies to improve their studies and advance cancer prevention, detection, diagnosis, and treatment.

This funding opportunity is designed for researchers with existing NCI R01 grants to integrate innovative cancer research technologies into their projects, enhancing the study's impact and advancing the field of cancer research.

This grant provides funding for collaborative research projects between academic institutions and industrial partners to develop and translate innovative technologies for disease diagnosis and treatment.

This grant provides funding to specialized cancer research centers to incorporate innovative technologies developed by the NCI, aiming to enhance cancer prevention, detection, and treatment efforts.

Not Available

This funding opportunity supports research using human-derived ex vivo models to explore how HIV interacts with addictive substances, focusing on their effects on the brain and immune system.

This funding opportunity supports early-stage planning for the development of innovative HIV treatments and prevention strategies, targeting a wide range of eligible institutions and organizations.

This funding opportunity supports preclinical research to identify and test existing drugs or drug combinations for their potential to treat Alzheimer’s Disease and related dementias, encouraging collaboration between academic and industry partners.